[Smell and taste disorders in Spanish patients with mild COVID-19]. / Afectación del sentido del olfato y el gusto en la enfermedad leve por coronavirus (COVID-19) en pacientes españoles.
Neurologia
; 35(9): 633-638, 2020.
Article
em Es
| MEDLINE
| ID: mdl-38620347
ABSTRACT
Introduction:
Coronavirus disease 2019 (COVID-19) has spread rapidly throughout the world. Smell and/or taste disorders have emerged as a very frequent symptom as the disease has spread in Europe. Spain is one of the European countries with the highest number of infections.Objective:
This study aimed to investigate the clinical progression of smell and taste disorders in Spanish patients with mild COVID-19.Methods:
An online survey was used to conduct a cross-sectional study of patients who presented sudden smell and/or taste disorders during the 2 months of total lockdown due to COVID-19 in Spain.Results:
In our sample, 91.18% of respondents with impaired smell and/or taste and who were able to undergo PCR testing were positive for SARS-CoV-2 infection. Anosmia and ageusia presented in isolation in 6.5% of participants. The remaining 93.5% presented other mild symptoms headache (51.6%), cough (51.6%), myalgia (45.2%), asthaenia (38.7%), nasal congestion or rhinorrhoea (35.5%), fever (41.9%), low-grade fever (29.0%), odynophagia (25.8%), or diarrhoea (6.5%). The mean duration of anosmia was 8.33 days, with patients subsequently manifesting hyposmia; complete resolution occurred after a mean of 17.79 days. In 22.6% of respondents, olfactory deficits persisted. All participants recovered their sense of taste.Conclusions:
Olfactory and gustatory disorders are prevalent symptoms in mild COVID-19. Most patients do not present associated nasal congestion or rhinorrhoea and a small group of patients present these alterations in isolation.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
Es
Revista:
Neurologia
Assunto da revista:
NEUROLOGIA
Ano de publicação:
2020
Tipo de documento:
Article